Home > > > > Report Detail

2022-2030 Report on Global Biosimilar Monoclonal Antibodies Market by Player, Region, Type, Application and Sales Channel

Publisher Name :
Date: 13-Jun-2022
No. of pages: 103

This report studies the Biosimilar Monoclonal Antibodies market, covering market size for segment by type (Infliximab, Rituximab, etc.), by application (Oncology, Autoimmune Disease, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), Dr Reddy's, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Biosimilar Monoclonal Antibodies from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biosimilar Monoclonal Antibodies market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Biosimilar Monoclonal Antibodies including:

- Celltrion

- Pfizer (Hospira)

- 3SBIO

- Novartis (Sandoz)

- Dr Reddy's

- Celgen Biopharma

- Cadila Healthcare

- Hisun Pharma

- Torrent Pharmaceuticals

- Biocon

Market split by Type, can be divided into:

- Infliximab

- Rituximab

- Trastuzumab

- Adalimumab

- Others

Market split by Application, can be divided into:

- Oncology

- Autoimmune Disease

- Others

Market split by Sales Channel, can be divided into:

- Direct Channel

- Distribution Channel

Market segment by Region/Country including:

- North America (United States, Canada and Mexico)

- Europe (Germany, UK, France, Italy, Russia and Spain etc.)

- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

- South America (Brazil, Argentina and Colombia etc.)

- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

2022-2030 Report on Global Biosimilar Monoclonal Antibodies Market by Player, Region, Type, Application and Sales Channel

Table of Contents

Chapter 1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Biosimilar Monoclonal Antibodies Definition
1.2 Global Biosimilar Monoclonal Antibodies Market Size Status and Outlook (2016-2030)
1.3 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Region (2016-2030)
1.4 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Type (2016-2030)
1.5 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Application (2016-2030)
1.6 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Sales Channel (2016-2030)
1.7 Biosimilar Monoclonal Antibodies Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19

Chapter 2 Biosimilar Monoclonal Antibodies Market Segment Analysis by Player
2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Player (2019-2021)
2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2019-2021)
2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player

Chapter 3 Biosimilar Monoclonal Antibodies Market Segment Analysis by Type
3.1 Global Biosimilar Monoclonal Antibodies Market by Type
3.1.1 Infliximab
3.1.2 Rituximab
3.1.3 Trastuzumab
3.1.4 Adalimumab
3.1.5 Others
3.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2016-2021)
3.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2016-2021)
3.4 Global Biosimilar Monoclonal Antibodies Average Price by Type (2016-2021)
3.5 Leading Players of Biosimilar Monoclonal Antibodies by Type in 2021
3.6 Conclusion of Segment by Type

Chapter 4 Biosimilar Monoclonal Antibodies Market Segment Analysis by Application
4.1 Global Biosimilar Monoclonal Antibodies Market by Application
4.1.1 Oncology
4.1.2 Autoimmune Disease
4.1.3 Others
4.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2021
4.4 Conclusion of Segment by Application

Chapter 5 Biosimilar Monoclonal Antibodies Market Segment Analysis by Sales Channel
5.1 Global Biosimilar Monoclonal Antibodies Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel

Chapter 6 Biosimilar Monoclonal Antibodies Market Segment Analysis by Region
6.1 Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2016-2030)
6.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2016-2021)
6.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Monoclonal Antibodies Market Share by Type
6.4.3 North America Biosimilar Monoclonal Antibodies Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Monoclonal Antibodies Market Share by Type
6.5.3 Europe Biosimilar Monoclonal Antibodies Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type
6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Monoclonal Antibodies Market Share by Type
6.7.3 South America Biosimilar Monoclonal Antibodies Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type
6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies Players
7.1 Celltrion
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Pfizer (Hospira)
7.3 3SBIO
7.4 Novartis (Sandoz)
7.5 Dr Reddy's
7.6 Celgen Biopharma
7.7 Cadila Healthcare
7.8 Hisun Pharma
7.9 Torrent Pharmaceuticals
7.10 Biocon

Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies
8.1 Industrial Chain of Biosimilar Monoclonal Antibodies
8.2 Upstream of Biosimilar Monoclonal Antibodies
8.3 Downstream of Biosimilar Monoclonal Antibodies

Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (2022-2030)
9.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2022-2030)

Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

List of Tables and Figures

Figure Biosimilar Monoclonal Antibodies Example
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Biosimilar Monoclonal Antibodies Sales by Player (2019-2021)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Player (2019-2021)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Player in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Player (2019-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player (2019-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player in 2021
Table Global Biosimilar Monoclonal Antibodies Average Price by Player (2019-2021)
Figure Global Biosimilar Monoclonal Antibodies Average Price by Player in 2021
Figure Global Biosimilar Monoclonal Antibodies Players Competition Situation - Top 5 Players' Revenue Market Share in 2019
Figure Global Biosimilar Monoclonal Antibodies Players Competition Trends - Top 5 Players' Revenue Market Share in 2021
Figure Example of Infliximab
Figure Global Infliximab Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Rituximab
Figure Global Rituximab Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Trastuzumab
Figure Global Trastuzumab Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Adalimumab
Figure Global Adalimumab Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Sales by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2021
Table Global Biosimilar Monoclonal Antibodies Average Price by Type (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Average Price by Type in 2021
Table Leading Players of Biosimilar Monoclonal Antibodies by Type in 2021
Figure Example of Oncology
Figure Global Biosimilar Monoclonal Antibodies for Oncology Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Autoimmune Disease
Figure Global Biosimilar Monoclonal Antibodies for Autoimmune Disease Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Biosimilar Monoclonal Antibodies for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Sales by Application (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2021
Table Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2021
Figure Example of Direct Channel
Figure Global Biosimilar Monoclonal Antibodies for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Biosimilar Monoclonal Antibodies for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue by Sales Channel (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Sales Channel (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2021
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2016-2030)
Table Global Biosimilar Monoclonal Antibodies Sales by Region (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Region (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2021
Table North America Biosimilar Monoclonal Antibodies Sales by Country (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table North America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Market Share by Type in 2021
Figure North America Biosimilar Monoclonal Antibodies Market Share by Application in 2021
Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure United States Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Canada Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Sales by Country (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Market Share by Type in 2021
Figure Europe Biosimilar Monoclonal Antibodies Market Share by Application in 2021
Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Germany Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure UK Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure France Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Italy Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Russia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Spain Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Country (2016-2021)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type in 2021
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application in 2021
Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure China Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Korea Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure India Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Australia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Table South America Biosimilar Monoclonal Antibodies Sales by Country (2016-2021)
Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table South America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021)
Figure South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Figure South America Biosimilar Monoclonal Antibodies Market Share by Type in 2021
Figure South America Biosimilar Monoclonal Antibodies Market Share by Application in 2021
Figure Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Argentina Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Colombia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Country (2016-2021)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type in 2021
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application in 2021
Figure UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure UAE Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Celltrion
Table Biosimilar Monoclonal Antibodies Introduction of Celltrion
Table Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share of Celltrion (2019-2021)
Table Industrial Chain of Biosimilar Monoclonal Antibodies
Table Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Table General Manufacturing Process of Biosimilar Monoclonal Antibodies
Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies
Table Leading Consumers of Biosimilar Monoclonal Antibodies
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2022-2030)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2022-2030)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2022-2030)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2022-2030)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2022-2030)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2022-2030)


  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs